ANKRD22 and familial pancreatic carcinoma: There are few studies on ankyrin repeat domain 22 (ANKRD22) and related studies in medicine that have shown that the expression levels of ANKRD22 in human breast cancer [49] and pancreatic cancer [50] tissues are significantly higher than those in normal breast tissues.